Barberry (Berberis vulgaris L.) is a safe approach for management of lipid parameters: A systematic review and meta‐analysis of randomized controlled trials
- 1 April 2019
- journal article
- review article
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 43, 117-124
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- In vitro biological assessment of berberis vulgaris and its active constituent, berberine: antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effectsBMC Complementary and Alternative Medicine, 2013
- Hypoglycaemic effect of Berberis vulgaris L. in normal and streptozotocin-induced diabetic ratsAsian Pacific Journal of Tropical Biomedicine, 2011
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- SOME PHYSICOMECHANICAL AND NUTRITIONAL PROPERTIES OF BARBERRY (BERBERIS VULGARIS L.) FRUITSJournal of Food Process Engineering, 2009
- AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activityNature, 2009
- Pharmacological and therapeutic effects ofBerberis vulgarisand its active constituent, berberinePhytotherapy Research, 2008
- The cumulative effect of core lifestyle behaviours on the prevalence of hypertension and dyslipidemiaBMC Public Health, 2008
- Diabetic Dyslipidemia and AtherosclerosisClinical Cornerstone, 2008
- Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase With Beneficial Metabolic Effects in Diabetic and Insulin-Resistant StatesDiabetes, 2006
- A pharmacological study on Berberis vulgaris fruit extractJournal of Ethnopharmacology, 2005